Literature DB >> 16901008

Clinicopathologic roles of tumor-infiltrating lymphocytes and CD8-positive lymphocytes in lung cancer imprint smears in squamous cell carcinoma and adenocarcinoma.

Satoshi Ikeda1, Naoya Funakoshi, Masaharu Inagaki, Toshikatsu Shibata.   

Abstract

OBJECTIVE: To investigate the presence of tumor-infiltrating lymphocytes (TILs) and CD8-positive lymphocytes (CD8s) in lung cancers and to examine the prognostic significance of their relationship with clinicopathologic parameters. STUDY
DESIGN: Primary tumor imprint smears from 83 lung cancers were consecutively obtained at surgery at Tsuchiura Kyodo General Hospital between 1996 and 1998. TILs were observed in Papanicolaou-stained smears, and CD8s were immunocytochemically visualized.
RESULTS: TILs were judged positive in 42 cases (51%), and 34 of 83 cases (41%) were positive for CD8s. There was no correlation between the frequency of TILs and CD8s. TILs assessed by Papanicolaou staining in 83 cases showed no correlation with any clinicopathologic factors. CD8s were observed more frequently in squamous cell carcinomas (SCCs) than other adenocarcinomas. A high frequency of CD8s was associated with lymph node metastasis (p = 0.043), stage (p = 0.025) and tumor differentiation (p = 0.03). TILs and CD8s made no significant difference in survival. However, in SCC the patients positive for TILs but negative for CD8s survived and had a significantly better prognosis than did the others (p = 0.037).
CONCLUSION: CD8s were associated with tumor progression and development of malignancy in lung cancers. Especially in SCC, the cases had a high frequency of TILs. A low number of CD8s may correlate with a favorable prognosis.

Entities:  

Mesh:

Year:  2006        PMID: 16901008     DOI: 10.1159/000325986

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  4 in total

1.  Adoptive immunotherapy using T lymphocytes redirected to glypican-3 for the treatment of lung squamous cell carcinoma.

Authors:  Kesang Li; Xiaorong Pan; Yanyu Bi; Wen Xu; Cheng Chen; Huiping Gao; Bizhi Shi; Hua Jiang; Shengli Yang; Liyan Jiang; Zonghai Li
Journal:  Oncotarget       Date:  2016-01-19

2.  Prognostic and predictive value of tumor-infiltrating lymphocytes for clinical therapeutic research in patients with non-small cell lung cancer.

Authors:  Dong-Qiang Zeng; Yun-Fang Yu; Qi-Yun Ou; Xiao-Yin Li; Ru-Zhi Zhong; Chuan-Miao Xie; Qiu-Gen Hu
Journal:  Oncotarget       Date:  2016-03-22

Review 3.  Unmet needs in squamous cell carcinoma of the lung: potential role for immunotherapy.

Authors:  Thomas E Stinchcombe
Journal:  Med Oncol       Date:  2014-04-19       Impact factor: 3.064

4.  Prognostic value of the common tumour-infiltrating lymphocyte subtypes for patients with non-small cell lung cancer: A meta-analysis.

Authors:  Benchao Chen; Heng Li; Chao Liu; Xudong Xiang; Shuting Wang; Anhao Wu; Yan Shen; Gaofeng Li
Journal:  PLoS One       Date:  2020-11-10       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.